Cargando…
AstraZeneca COVID-19 vaccine: EMA continues review of rare blood clots
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035857/ http://dx.doi.org/10.1007/s40278-021-93807-0 |
Ejemplares similares
-
EMA assessing cases of blood clots after AstraZeneca COVID-19 vaccine
Publicado: (2021) -
Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Health Canada: blood clots with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Benefits of COVID-19 Vaccine AstraZeneca outweigh risks of blood clots
Publicado: (2021) -
Ongoing evaluation of COVID-19 Vaccine AstraZeneca-related blood clots
Publicado: (2021)